Trials / Enrolling By Invitation
Enrolling By InvitationNCT05616884
Cemented vs. Cementless Unicompartmental Knee Arthroplasty
A Prospective, Randomized Study Comparing Cemented and Cementless Fixed Bearing Unicondylar Medial Knee Replacement
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Anderson Orthopaedic Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The primary study objective is to evaluate a cementless partial knee system that has a modular 3-D printed porous metal tibial component and a cemented partial knee system. The hypothesis is that at minimum 2-year follow-up, fixed bearing medial partial knee replacements using cementless and cemented fixation will demonstrate no differences in clinical outcome.
Detailed description
This is a prospective, randomized, unblinded clinical trial of 100 patients will be enrolled by invitation of the principal investigator. Inclusion criteria include patients 18-85 years old, patients receiving a medial fixed bearing partial knee replacement and patients deemed suitable for both cemented and cementless fixation after review of the preoperative radiographs. Minimum two-year outcome will be analyzed, and long-term follow-up will continue to 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cementless fixation | Three dimensional printed porous metal, a biomaterial with morphological and mechanical properties that resemble those of native trabecular bone, is now being used for fixation of the tibial component in unicondylar knee arthroplasty. This can reliably achieve osseointegration into the tibia and could lead to a lower risk of aseptic loosening which is the leading cause of revision in partial knee replacements. |
Timeline
- Start date
- 2022-07-08
- Primary completion
- 2025-12-30
- Completion
- 2026-12-30
- First posted
- 2022-11-15
- Last updated
- 2023-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05616884. Inclusion in this directory is not an endorsement.